Friday, Jan 19, 2024 · SEC filings

What the smart money revealed on Jan 19

Real insider buys30insiders · $3.35M
Real insider sales34insiders · $18.2M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

366 insider filings came in. We hid 47 planned (10b5-1) sellers and 222 people whose filings were routine, like grants and tax withholding.

trending_up

Palmer Square Capital BDC (PSBD) President Matthew Bloomfield bought $1M

60,790 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 17
$1M
trending_up

Palmer Square Capital BDC (PSBD) Chief Investment Officer Angie Long bought $1M

60,790 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 17
$1M
trending_up

Olb Group (OLB) Chairman and CEO Ronny Yakov bought $604K

784,212 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 16
$604K
trending_up

Olb Group (OLB) Vice President Patrick Smith bought $302K

392,106 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 16
$302K
trending_down

Goldman Sachs Group (GS) Chief Risk Officer Brian Lee sold $3.57M

Not marked as a planned 10b5-1 sale. Sold 28% of the shares they held directly. Still holds 24,429 shares.

Real sale Form 4 Sold 28% of stake Traded Jan 17
$3.57M
trending_down

Atlassian (TEAM) Co-CEO Michael Cannon-Brookes sold $1.97M

Not marked as a planned 10b5-1 sale. Sold 2% of the shares they held directly. Still holds 403,809 shares.

Real sale Form 4 Traded Jan 18
$1.97M
trending_down

Acuity Brands (AYI) SVP and Chief HR Officer Dianne Mills sold $1.35M

Not marked as a planned 10b5-1 sale. Sold 41% of the shares they held directly. Still holds 8,554 shares.

Real sale Form 4 Sold 41% of stake Traded Jan 18
$1.35M
Show 26 more real buys
CME CME Group · Director William Shepard · Traded Jan 18
$281K
PPTA Perpetua Resources · Director Chris Robison · Traded Jan 18
$29.5K
TPL Texas Pacific Land · Director Murray Stahl · Traded Jan 18
$17.8K
GAM General American Investors · Senior Vice President Anang Majmudar · Traded Jan 19
$17.1K
YORW York Water · President and CEO Joseph Hand · Traded Jan 17
$9.75K
BCAB BioAtla · Director Sylvia McBrinn · Traded Mar 28 · Filed late
$9.4K
TGEN Tecogen · Director John Hatsopoulos · Traded Jan 18
$7.3K
Davey Tree Expert · VP and GM James Houston · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · EVP Gregory Ina · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · EVP and CFO Joseph Paul · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · EVP Brent Repenning · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · VP Erika Schoenberger · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · Vice President and Controller Thea Sears · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · Chairman Patrick Covey · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · EVP and GM Lawrence Evans · Traded Dec 30 · Filed late
$6.56K
Davey Tree Expert · EVP Joseph Day III · Traded Dec 30 · Filed late
$6.56K
RVP Retractable Technologies · President and CEO Thomas Shaw · Traded Jan 17–18
$5.39K
Davey Tree Expert · EVP and Assistant to President Dan Joy · Traded Dec 30 · Filed late
$5.25K
YORW York Water · CAO and General Counsel Alexandra Chiaruttini · Traded Jan 17
$1.3K
VANI Vivani Medical · Director Gregg Williams · Traded Jan 18–19
$1.09K
Davey Tree Expert · EVP and GM James Doyle · Traded Dec 30 · Filed late
$990
YORW York Water · VP- Customer Service Vernon Bracey · Traded Jan 17
$910
YORW York Water · VP- Human Resources Natalee Colon · Traded Jan 17
$507
YORW York Water · VP- Engineering Mark Snyder · Traded Jan 17
$325
YORW York Water · CFO Matthew Poff · Traded Jan 17
$130
RCG RENN Fund · President and CEO Murray Stahl · Traded Jan 18
$126
Show 31 more real sales
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Jan 18
$1.97M
ANTX AN2 Therapeutics · Director Joseph Zakrzewski · Traded Jan 18
$1.91M
SNX TD SYNNEX · Head of Hyve Solutions Dennis Polk · Traded Jan 17
$1.28M
PGR Progressive · President and CEO Susan Griffith · Traded Jan 17
$1.01M
MS Morgan Stanley · Co-President Andrew Saperstein · Traded Jan 19
$841K
DLB Dolby Laboratories · President and CEO Kevin Yeaman · Traded Jan 17
$754K
MS Morgan Stanley · Deputy CFO Raja Akram · Traded Jan 18
$585K
SNX TD SYNNEX · Americas President Michael Urban · Traded Jan 17
$520K
USB US Bancorp · Vice Chair Timothy Welsh · Traded Jan 18
$488K
SNX TD SYNNEX · Director Fred Breidenbach · Traded Jan 17
$399K
CMGR Clubhouse Media Group · COO Simon Yu · Traded Oct 19–Dec 8 · Filed late
$285K
PGR Progressive · CRM President Lori Niederst · Traded Jan 17
$219K
CABA Cabaletta Bio · President Gwendolyn Binder · Traded Jan 19
$215K
RNR RenaissanceRe · EVP David Marra · Traded Jan 17
$209K
FSLY Fastly · CFO Ronald Kisling · Traded Jan 17
$98.8K
PGR Progressive · Chief Strategy Officer Andrew Quigg · Traded Jan 17
$93.3K
AEHR Aehr Test Systems · President and CEO Gayn Erickson · Traded Jan 18
$84.7K
SGHT Sight Sciences · President and CEO Paul Badawi · Traded Jan 17
$82.1K
SGHT Sight Sciences · COO Sam Park · Traded Jan 17
$28.1K
EDR Endeavor Group · Global Controller and CAO William Fullerton · Traded Jan 18
$26.7K
SGHT Sight Sciences · Chief Legal Officer Jeremy Hayden · Traded Jan 17
$23.4K
CLSD Clearside Biomedical · CEO George Lasezkay · Traded Jan 19
$22.9K
AEHR Aehr Test Systems · Exec VP of Sales and Mktg. Vernon Rogers · Traded Jan 18
$22.8K
VYGR Voyager Therapeutics · COO Robin Swartz · Traded Jan 17
$18.2K
AEHR Aehr Test Systems · CTO Donald Richmond II · Traded Jan 18
$17.8K
SGHT Sight Sciences · CTO David Badawi · Traded Jan 17
$17.6K
IMVT Immunovant · Chief Medical Officer William Macias · Traded Jan 18
$17.4K
CLSD Clearside Biomedical · CFO Charles Deignan · Traded Jan 19
$16.5K
VYGR Voyager Therapeutics · Chief Scientific Officer Todd Carter · Traded Jan 17
$9.09K
STEM Stem · Chief Accounting Officer Rahul Shukla · Traded Jan 19
$9.04K
ISTR Investar Holding · Director Gordon Joffrion III · Traded Dec 19–Nov 14 · Filed late
$610

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Jan 13–19

Open-market buys by officers and directors, filed in the 7 days up to Jan 19.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist